Specialist Pharmacovigilance Course Europe
One of the most experienced pharmacovigilance and pharmacoepidemiology experts in the world.
Professor Saad Shakir
Global Expert in Pharmacovigilance & Pharmacoepidemiology
★★★★★
“Collaborating with Professor Saad Shakir at Adroit Vigilance has significantly benefited our organisation. His pharmacovigilance and pharmacoepidemiology expertise deepens our drug safety understanding and fosters team adaptability. His guidance enhances patient outcomes and ensures proactive industry responses. We value his impactful commitment to excellence.”
– Dr. Edmund Burke
Pharmacovigilance Course Europe
Pharmacovigilance Course Europe
Pharmacovigilance Course Europe
Professor Saad Shakir is a recognised authority in pharmacoepidemiology and drug safety, with extensive international expertise in pharmacovigilance, regulatory governance, and risk management. Through Pharmacovigilance Training UK, he delivers a specialist Pharmacovigilance Course Europe, providing high-level, tailored training for pharmaceutical companies, regulators, and healthcare organisations across Europe, the UK, the US, and globally.
His distinguished career includes senior leadership roles within the UK regulatory authority, GSK, and RPR, followed by his appointment as Director of the Drug Safety Research Unit in Southampton. In June 2025, Professor Shakir established an independent consultancy, offering expert drug safety advice alongside advanced Pharmacovigilance Course Europe programmes and bespoke international training solutions.
Through Pharmacovigilance Training UK, Professor Shakir addresses complex drug safety challenges, including risk management planning, regulatory submissions, product withdrawals, and the design and implementation of large-scale pharmacovigilance systems. His teaching integrates clinical insight with advanced epidemiological methodologies, supporting post-authorisation safety studies, real-world evidence generation, and robust risk minimisation strategies aligned with EU, UK, US, and international regulatory requirements.
He also provides strategic oversight for safety submissions and regulatory responses, working closely with multinational pharmaceutical organisations, as well as mid-sized and emerging life sciences companies across Europe and internationally. Professor Shakir has extensive experience engaging with regulatory authorities and global institutions and regularly serves on Safety Advisory Boards and Data Safety Monitoring Committees.
A prolific academic, Professor Shakir has published extensively in peer-reviewed journals, book chapters, and conference proceedings on pharmacovigilance, pharmacoepidemiology, and drug safety risk management. He serves on editorial boards for leading publications, including Drug Safety and Pharmacoepidemiology and Drug Safety.
Committed to advancing global standards in medicine safety, Professor Shakir continues to deliver high-level Pharmacovigilance Course Europe programmes and international training sessions, sharing best practice and regulatory expertise at scientific and regulatory conferences worldwide.
Professor Saad Shakir
MB ChB, LRCP&S FRCP FISPE MRCGP
Global Drug Safety Consultancy & Pharmacovigilance Course Europe
Pharmacovigilance Course Europe
Saad Shakir is a highly respected authority in pharmacoepidemiology and drug safety, internationally recognised for his expertise in pharmacovigilance, regulatory drug safety, and pharmacoepidemiology across the UK, Europe, the United States, and global markets. Through Pharmacovigilance Training UK, he provides specialist consultancy and delivers a leading Pharmacovigilance Course Europe, supporting pharmaceutical companies, life sciences organisations, and regulatory stakeholders in achieving best practice, regulatory compliance, and operational excellence in drug safety.
His distinguished career includes senior leadership roles within the UK regulatory authority, GSK, and RPR, followed by his appointment as Director of the Drug Safety Research Unit in Southampton. This breadth of experience spans regulatory, commercial, and academic environments and is underpinned by in-depth knowledge of UK, EU, US, and international regulatory frameworks. This enables him to support organisations operating across Europe and internationally with confidence and authority.
In June 2025, Saad founded his independent consultancy, Adroit Vigilance, providing expert pharmacovigilance advisory services, advanced professional training, and strategic drug safety support. Through Pharmacovigilance Training UK, he delivers a comprehensive Pharmacovigilance Course Europe, helping organisations strengthen pharmacovigilance systems, improve regulatory compliance, and implement robust risk management strategies aligned with EU, UK, US, and international regulatory requirements.
Our Services
Ensuring medicine safety is fundamental to protecting patient wellbeing and maintaining confidence in healthcare systems. Pharmacovigilance Training UK delivers a specialist Pharmacovigilance Course Europe, equipping organisations with the knowledge and practical skills required to monitor adverse drug reactions, conduct robust risk assessments, and implement effective risk minimisation strategies in line with EU, UK, US, and international regulatory standards.
Through the structured collection, analysis, and interpretation of safety data, the Pharmacovigilance Course Europe enables participants to identify potential medicine-related risks at an early stage. This supports evidence-based clinical decision-making and timely regulatory intervention where required. Healthcare and life sciences professionals develop hands-on expertise to ensure the safe and appropriate use of medicines, prevent misuse, and uphold high standards of pharmacovigilance practice.
With a strong emphasis on patient safety, regulatory compliance, and therapeutic effectiveness, the Pharmacovigilance Course Europe helps improve patient outcomes while strengthening long-term trust in healthcare providers, regulatory frameworks, and pharmaceutical products.
Consultancy & Advice
We provide expert consultancy and advice in the fields of pharmacovigilance and pharmacoepidemiology. Our services include:
Risk Management: We handle risk management and risk minimization, including monitoring its effectiveness.
Safety Studies: We conduct Real World Studies and PASS (Post-Authorisation Safety Studies).
Benefit/Risk Evaluation: We perform thorough benefit/risk evaluations.
Regulatory Submissions: We assist with pharmacovigilance submissions and responses to regulatory authorities.
ADR Assessment: We provide assessment of single and clusters of Adverse Drug Reaction (ADR) reports.
Specialised Boards: Saad is experienced in working with Data Safety Management Boards and Advisory Committees.
Medicolegal Work: We also undertake medicolegal work.
Training & Education
Our courses provide essential knowledge and practical skills for the safe handling, management, and administration of medicines. Through Pharmacovigilance Training UK, participants complete structured modules covering drug classifications, adverse effects, and best-practice guidance for storage, handling, and disposal. Learning is enhanced through expert-led sessions, real-world case studies, and practical exercises, enabling attendees to identify, assess, and mitigate medication-related risks across diverse settings. Strong emphasis is placed on regulatory compliance, ethical responsibility, and patient safety, equipping healthcare professionals, pharmacists, and medicines management teams with the confidence to uphold the highest standards of care.
We are committed to training and education on a wide range of topics in pharmacovigilance and pharmacoepidemiology. Our training is delivered through various formats:
Delivery Methods: Training can be delivered online, hybrid, or face-to-face.
Training Options: We offer in-house training, specific training courses, and conferences.
Collaborative Projects
As a recognised authority in pharmacoepidemiology, we actively contribute to international collaborations aimed at advancing pharmacovigilance standards and safeguarding patient wellbeing. Through Pharmacovigilance Training UK, we deliver a comprehensive Pharmacovigilance Course Europe that supports innovation in drug safety, reinforces regulatory best practice, and promotes consistent compliance across UK, European, US, and global regulatory frameworks.
The Pharmacovigilance Course Europe supports organisations in developing robust pharmacovigilance systems, strengthening risk management processes, and enabling evidence-based regulatory decision-making. By sharing practical insight and international expertise, the programme equips healthcare and life sciences professionals with the skills required to improve patient outcomes and maintain the highest standards of drug safety across Europe, the UK, and global healthcare markets.
For general enquiries about AdroitVigilance and our services or courses, please fill out the form provided.
If you wish to engage Professor Saad Shakir, a leading consultant in pharmacoepidemiology, for expert advisory services, speaking engagements, or a Pharmacovigilance Course Europe, please complete the enquiry form provided. For urgent matters, Professor Shakir may also be contacted directly using the details listed, although response times may vary due to international professional commitments.
To ensure the most appropriate and effective support, we recommend including clear and comprehensive information about your objectives and requirements. Alternatively, you may contact us by email or telephone to arrange a consultation or a bespoke Pharmacovigilance Course Europe delivered by an experienced pharmacoepidemiology and drug safety specialist.